Advertisement

Disease phenotype and outcomes of very early-onset inflammatory bowel disease

  • Valeria Dipasquale
    Affiliations
    Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Messina, Italy
    Search for articles by this author
  • Giovanna Lo Presti
    Affiliations
    Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Messina, Italy
    Search for articles by this author
  • Claudio Romano
    Correspondence
    Corresponding author at: Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Via Consolare Valeria 1, Messina, 98124, Italy
    Affiliations
    Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Messina, Italy
    Search for articles by this author
      Dear Editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vernier-Massouille G
        • Balde M
        • Salleron J
        • et al.
        Natural history of pediatric Crohn’s disease: A population-based cohort study.
        Gastroenterology. 2008; 135: 1106-1113
        • Benchimol EI
        • Bernstein CN
        • Bitton A
        • et al.
        Trends in epidemiology of pediatric inflammatory bowel disease in Canada: Distributed network analysis of multiple population based provincial health administrative databases.
        Am J Gastroenterol. 2017; 112: 1120-1134
        • Kelsen JR
        • Sullivan KE
        • Rabizadeh S
        • et al.
        North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease.
        J Pediatr Gastroenterol Nutr. 2020; 70: 389-403
        • Bramuzzo M
        • Arrigo S
        • Romano C
        • et al.
        Efficacy and safety of infliximab in very early onset inflammatory bowel disease: A national comparative retrospective study.
        United European Gastroenterol J. 2019; 7: 759-766
        • Romeo AC
        • Ventimiglia M
        • Dipasquale V
        • et al.
        Effectiveness and safety of biologics in pediatric inflammatory bowel disease: Real-life data from the Sicilian network.
        Clin Res Hepatol Gastroenterol. 2020; 44: 223-229
        • Gupta N
        • Bostrom AG
        • Kirschner BS
        • et al.
        Presentation and disease course in early- compared to later-onset pediatric Crohn's disease.
        Am J Gastroenterol. 2008; 103: 2092-2098
        • Turner D
        • Ruemmele FM
        • Orlanski-Meyer E
        • et al.
        Management of paediatric ulcerative colitis, part 1: Ambulatory care-an evidence-based guideline from European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
        J Pediatr Gastroenterol Nutr. 2018; 67: 257-291
        • Dotan I
        • Ron Y
        • Yanai H
        • et al.
        Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: A population pharmacokinetic study.
        Inflamm Bowel Dis. 2014; 20: 2247-2259
        • Jongsma MME
        • Winter DA
        • Huynh HQ
        • et al.
        Infliximab in young paediatric IBD patients: It is all about the dosing.
        Eur J Pediatr. 2020; 179: 1935-1944
        • van Rheenen PF
        • Aloi M
        • Assa A
        • et al.
        The medical management of paediatric Crohn's disease: An ECCO-ESPGHAN guideline update.
        J Crohns Colitis. 2020; : jjaa161